title: Tolerance to lipopolysaccharide promotes an enhanced neutrophil extracellular traps formation leading to a more efficient bacterial clearance in mice.
abstract: Tolerance to lipopolysaccharide (LPS) constitutes a stress adaptation, in which a primary contact with LPS results in a minimal response when a second exposure with the same stimulus occurs. However, active important defence mechanisms are mounted during the tolerant state. Our aim was to assess the contribution of polymorphonuclear neutrophils (PMN) in the clearance of bacterial infection in a mouse model of tolerance to LPS. After tolerance was developed, we investigated in vivo different mechanisms of bacterial clearance. The elimination of a locally induced polymicrobial challenge was more efficient in tolerant mice both in the presence or absence of local macrophages. This was related to a higher number of PMN migrating to the infectious site as a result of an increased number of PMN from the marginal pool with higher chemotactic capacity, not because of differences in their phagocytic activity or reactive species production. In vivo, neutrophils extracellular trap (NET) destruction by nuclease treatment abolished the observed increased clearance in tolerant but not in control mice. In line with this finding, in vitro NETs formation was higher in PMN from tolerant animals. These results indicate that the higher chemotactic response from an increased PMN marginal pool and the NETs enhanced forming capacity are the main mechanisms mediating bacterial clearance in tolerant mice. To sum up, far from being a lack of response, tolerance to LPS causes PMN priming effects which favour distant and local anti-infectious responses.
authors.affiliation: Immunology Department of the Instituto de Medicina Experimental, Academia Nacional de Medicina de Buenos Aires, Argentina. vilandoni@yahoo.com.ar
authors.forename: V I
authors.initials: VI
authors.lastname: Landoni
authors.forename: P
authors.initials: P
authors.lastname: Chiarella
authors.forename: D
authors.initials: D
authors.lastname: Martire-Greco
authors.forename: P
authors.initials: P
authors.lastname: Schierloh
authors.forename: N
authors.initials: N
authors.lastname: van-Rooijen
authors.forename: B
authors.initials: B
authors.lastname: Rearte
authors.forename: M S
authors.initials: MS
authors.lastname: Palermo
authors.forename: M A
authors.initials: MA
authors.lastname: Isturiz
authors.forename: G C
authors.initials: GC
authors.lastname: Fernández
mesh_terms: D000818:Animals; D001424:Bacterial Infections / Q000276:immunology* / Q000382:microbiology; D002634:Chemotaxis, Leukocyte; D016983:Enterococcus / Q000276:immunology* / Q000472:pathogenicity; D007108:Immune Tolerance; D008070:Lipopolysaccharides / Q000276:immunology*; D017737:Macrophages, Peritoneal / Q000276:immunology / Q000382:microbiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009504:Neutrophils / Q000276:immunology* / Q000502:physiology; D010587:Phagocytosis; D026361:Reactive Nitrogen Species / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D013291:Streptococcus / Q000276:immunology* / Q000472:pathogenicity
chemical_list: D008070:Lipopolysaccharides; D026361:Reactive Nitrogen Species; D017382:Reactive Oxygen Species